German MECOTEC Group launches one-stop-solution for deep-freeze, transport, storage and distribution for COVID-19-Vaccines with its first Mobile Hybrid Container

PR86530

BITTERFELD-WOLFEN, Germany, Nov. 10, 2020 /PRNewswire=KYODO JBN/ --

·  Transport and storage of up to 1,000,000 vaccination doses with low

temperatures down to -80 degrees C/-112 degrees F

·  Active deep cooling technology ensures safe and controlled transport and storage

Vaccine manufacturers, transport and storage providers are facing major

challenges in the fight against the coronavirus. MECOTEC Group has announced a

complete-one-stop-solution consisting of: 1. Deep-freeze cooling + 2. Transport

+ 3. Storage & distribution of the vaccines: Immediately after production, the

vaccine is frozen in a deep cold storage and then loaded into a container,

transported afterwards safely to the distribution center at constant

temperatures down to - 80 degreesC / -112 degrees F. On site, the transport

container then functions as a storage and distribution center. It is supplied

via a three-phase power connection with 400V.

"Our many years of experience in the field of cooling technology made it

possible within a very short timeframe to develop the transport, storage and

distribution container," explains Jan Hüneburg, Managing Director at COOLANT,

the industrial division of MECOTEC.

"We are pleased that today we can present our Mobile Hybrid Container Solution

for the transport and storage of Covid-19-Vaccines globally," states the CEO of

MECOTEC Group Enrico Klauer. "Since our system is based on an active deep

freezing technology, it does not require dry ice for cooling which makes it

also suitable for safe carriage by air."

The complete solution developed by the MECOTEC Group can be used worldwide. "It

is our aim to get the vaccine to the people as soon as possible. Therefore we

offer several options: Orders for container production can be placed at MECOTEC

directly and at our worldwide sales offices. In addition we also offer licensed

production," says Klauer.

Full press release:

https://www.mecotec.net/en/first-mobile-hybrid-container-solution-for-covid-19-vaccines/ 

Dr. Karin Funke-Rapp

karin@funke-rapp.com

Tel.: +49 176/62755085

Photo - https://mma.prnewswire.com/media/1331027/MECOTEC_Hybrid_Container_Solution.jpg

Photo - https://mma.prnewswire.com/media/1331026/MECOTEC_COVID_19_Vaccines.jpg 

Source: MECOTEC GmbH